Literature DB >> 30394265

The Role of HNF1B in Tumorigenesis of Solid Tumours: a Review of Current Knowledge.

M Bártů1, P Dundr1, K Němejcová1, I Tichá1, H Hojný1, N Hájková1.   

Abstract

Hepatocyte nuclear factor 1-β is a transcription factor which plays a crucial role during ontogenesis in the differentiation of visceral endoderm from primitive endoderm, and is especially important for the normal development of the kidney, urogenital tract, gastrointestinal tract, liver, and pancreas. Despite the growing knowledge about the potential involvement of hepatocyte nuclear factor 1-β in the process of carcinogenesis, the exact underlying mechanism that would explain its rather varied effects in different tumours has not been sufficiently investigated. Most of the data regarding the significance of hepatocyte nuclear factor 1-β arise from genome- wide association studies and is concerned with the influence of single-nucleotide polymorphisms of hepatocyte nuclear factor 1-β on either the increased or decreased susceptibility to certain types of cancer. However, the influence of both the germinal and somatic mutations of this gene on the process of carcinogenesis is still poorly understood. According to current data, in some tumours hepatocyte nuclear factor 1-β acts as a protooncogene, while in others as a tumour suppressor gene, although the reasons for this are not clear. The exact incidence of hepatocyte nuclear factor 1-β mutations and the spectrum of tumours in which they may play a role in the process of carcinogenesis remain unknown. From the practical point of view, immunohistochemical expression of hepatocyte nuclear factor 1-β can be used in differential diagnostics of certain tumours, especially clear cell carcinoma. In our article we review the current knowledge regarding the significance of hepatocyte nuclear factor 1-β in carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30394265

Source DB:  PubMed          Journal:  Folia Biol (Praha)        ISSN: 0015-5500            Impact factor:   0.906


  4 in total

1.  Comprehensive quantitative analysis of alternative splicing variants reveals the HNF1B mRNA splicing pattern in various tumour and non-tumour tissues.

Authors:  Jan Hojny; Romana Michalkova; Eva Krkavcova; Quang Hiep Bui; Michaela Bartu; Kristyna Nemejcova; Marta Kalousova; Petra Kleiblova; Pavel Dundr; Ivana Struzinska
Journal:  Sci Rep       Date:  2022-01-07       Impact factor: 4.379

2.  Integrative Analysis of HNF1B mRNA in Human Cancers Based on Data Mining.

Authors:  Chunhui Nie; Bei Wang; Baoquan Wang; Ning Lv; Enfan Zhang
Journal:  Int J Med Sci       Date:  2020-10-18       Impact factor: 3.738

3.  Analysis of expression, epigenetic, and genetic changes of HNF1B in 130 kidney tumours.

Authors:  Michaela Bártů; Jan Hojný; Nikola Hájková; Romana Michálková; Eva Krkavcová; Ladislav Hadravský; Lenka Kleissnerová; Quang Hiep Bui; Ivana Stružinská; Kristýna Němejcová; Otakar Čapoun; Monika Šlemendová; Pavel Dundr
Journal:  Sci Rep       Date:  2020-10-13       Impact factor: 4.379

4.  HNF1B, EZH2 and ECI2 in prostate carcinoma. Molecular, immunohistochemical and clinico-pathological study.

Authors:  Pavel Dundr; Michaela Bártů; Jan Hojný; Romana Michálková; Nikola Hájková; Ivana Stružinská; Eva Krkavcová; Ladislav Hadravský; Lenka Kleissnerová; Jana Kopejsková; Bui Quang Hiep; Kristýna Němejcová; Radek Jakša; Otakar Čapoun; Jakub Řezáč; Kateřina Jirsová; Věra Franková
Journal:  Sci Rep       Date:  2020-09-01       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.